• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

Professional Introduction to 2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic Acid (CAS No. 1261840-24-7)

2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid, identified by its CAS number 1261840-24-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of benzoic acid derivatives, characterized by its unique structural features that include a chloro substituent at the second position and a trifluoromethoxy group at the fourth position of the phenyl ring. The presence of these functional groups imparts distinct chemical properties and reactivity, making it a valuable intermediate in the synthesis of various biologically active molecules.

The< strong>2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid molecule exhibits a high degree of structural complexity, which contributes to its potential applications in drug discovery and development. The chloro group enhances electrophilicity, facilitating nucleophilic substitution reactions, while the trifluoromethoxy group introduces electron-withdrawing effects and metabolic stability. These characteristics make it an attractive candidate for further functionalization and derivatization to create novel pharmacophores.

In recent years, there has been a growing interest in benzoic acid derivatives due to their demonstrated efficacy in various therapeutic areas. Studies have shown that compounds containing the benzoic acid scaffold exhibit a wide range of biological activities, including anti-inflammatory, antioxidant, and antimicrobial properties. The specific arrangement of substituents in 2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid may contribute to its unique pharmacological profile, making it a promising candidate for further investigation.

One of the most compelling aspects of this compound is its potential role in the development of targeted therapies. The< strong>chloro and< strong>trifluoromethoxy groups provide multiple sites for chemical modification, allowing researchers to tailor the molecule's properties for specific biological targets. For instance, the electron-withdrawing nature of these groups can influence binding affinity and selectivity, which are critical factors in drug design.

The synthesis of< strong>2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and fluorination techniques, are often employed to achieve high yields and purity. These synthetic strategies highlight the compound's complexity and the expertise required to produce it on an industrial scale.

Evidence from recent scientific literature suggests that derivatives of benzoic acid have shown promise in preclinical studies as potential treatments for various diseases. For example, modifications to the benzoic acid core have led to the discovery of novel compounds with enhanced anti-cancer and anti-inflammatory activities. The< strong>2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid structure may serve as a foundation for developing such next-generation therapeutics.

The pharmacokinetic properties of< strong>2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid are also of great interest. The presence of fluorine atoms can influence metabolic stability and distribution within the body. Understanding these properties is crucial for optimizing drug delivery systems and ensuring therapeutic efficacy. Computational modeling and experimental studies are often used to predict and verify these characteristics before moving into clinical trials.

In conclusion, 2-Chloro-4-2-(trifluoromethoxy)phenylbenzoic acid (CAS No. 1261840-24-7) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential biological activities. Its synthesis requires sophisticated organic techniques, and its applications in drug development are promising. As research continues to uncover new therapeutic targets and methodologies, compounds like this will play an increasingly important role in addressing unmet medical needs.

• 1261617-84-8(2-Chloro-6-trifluoromethoxy-benzoic acid)
• 1261984-90-0([1,1'-Biphenyl]-3-carboxylic acid, 4-chloro-3'-hydroxy-5'-(trifluoromethoxy)-)
• 1261855-01-9(2-Chloro-4-(3-trifluoromethoxyphenyl)benzoic acid)
• 1261686-35-4(6-Chloro-3'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid)
• 1261686-22-9(6-Chloro-2-(4-trifluoromethoxyphenyl)benzoic acid)
• 1261855-06-4(4-Chloro-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid)
• 1261455-21-3(2-Chloro-4-(4-trifluoromethoxyphenyl)benzoic acid)
• 1261836-04-7(2-Chloro-5-(trifluoromethoxy)benzoic acid)
• 1261855-17-7(6-Chloro-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid)
• 1261686-26-3(2-chloro-5-[3-(trifluoromethoxy)phenyl]benzoic Acid)